BUPROPION HYDROBROMIDE
Substance profile for UNII E70G3G5863, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- E70G3G5863
- Preferred term
- BUPROPION HYDROBROMIDE
- Registry number
- 905818-69-1
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C13H18ClNO.BrH
Chemical And Database Identifiers#
- SMILES
- Br.CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1
- RxCUI
- 993548
- PubChem
- 11984562
- NCIt
- C74947
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem Compound | 11984562 | https://pubchem.ncbi.nlm.nih.gov/compound/11984562 |
| RxNorm | 993548 | https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=993548 |
| NCI Thesaurus | C74947 | https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74947 |
| FDA Substance Registration System | E70G3G5863 | https://precision.fda.gov/uniisearch/srs/unii/E70G3G5863 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BUPROPION HYDROBROMIDE | ACTIVE INGREDIENT | E70G3G5863 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN (bupropion hydrobromide) tablet, film coated, extended release for oral use Initial U.S. Approval: 1985 | 1 | |
| BUPROPION HYDROBROMIDE | ACTIVE INGREDIENT | E70G3G5863 | APLENZIN (BUPROPION HYDROBROMIDE) TABLET, EXTENDED RELEASE [SANOFI-AVENTIS U.S. LLC] | 12 | |
| BUPROPION HYDROBROMIDE | ACTIVE INGREDIENT | E70G3G5863 | APLENZIN (BUPROPION HYDROBROMIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 2 |